← Open Payments lookup

ELIZABETH DOLAN: Open Payments

NPI 1417724295 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,800 in 94 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $741 · 2025 $1,800

Food & beverage: $1,800
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$387
ABBVIE INC.12$310
Vanda Pharmaceuticals Inc.9$183
E.R. Squibb & Sons, L.L.C.8$173
Alkermes, Inc.14$148
Axsome Therapeutics, Inc.9$142
Teva Pharmaceuticals USA, Inc.5$87
HARMONY BIOSCIENCES LLC4$84
Neurocrine BioSciences, Inc.4$74
Otsuka America Pharmaceutical, Inc.4$73

Products named: CAPLYTA, VRAYLAR, COBENFY, FANAPT, ARISTADA, Auvelity, WAKIX, INGREZZA.

Industry payments across NE — which companies pay providers there.